Bioidentical vs Compounded HRT: What to Know
Someone told you bioidentical hormones are safer and more natural. Someone else said compounded hormones are risky and unregulated. Your doctor handed you an FDA-approved estrogen patch and a prescription for micronized progesterone.
Now you are trying to figure out who to trust and whether these are even three different things.
Here is the honest answer: sometimes they overlap, sometimes they do not, and the marketing around all three has made it genuinely difficult to understand what you are actually being offered.
This article is for educational purposes only and does not constitute medical advice. It is meant to help you understand what each term means so you can have a more informed conversation with your clinician - not to replace that conversation.
The Short Answer
"Bioidentical" describes the molecular structure of a hormone - whether it matches what the human body produces. "Compounded" describes how a medication is prepared - custom-made by a compounding pharmacy rather than manufactured by a pharmaceutical company. "FDA-approved" describes the regulatory review process - whether a product has been evaluated for quality, consistency, safety labeling, and manufacturing standards.
These three terms are related but they are not the same thing.
Some FDA-approved HRT options are bioidentical. Estradiol patches, gels, and sprays, as well as oral micronized progesterone, are both bioidentical in structure and FDA-approved as finished products. Compounded hormones may or may not be bioidentical depending on what is in them. And FDA-approved does not mean synthetic any more than compounded means natural.
The term "bioidentical" has been used heavily in marketing in ways that go well beyond what the science supports.
What "Bioidentical" Actually Means
Bioidentical refers to hormones that are chemically identical in structure to the hormones the human body produces. Estradiol is bioidentical. Progesterone is bioidentical. These are not marketing terms - they are descriptions of molecular structure.
What the term does not mean is that a hormone is automatically safer, more effective, or better tolerated because it is bioidentical. Molecular structure is one variable in a clinical picture that also includes dose, route, formulation, individual response, and monitoring.
The wellness market has used "bioidentical" to imply naturalness and safety in ways that major professional bodies explicitly push back on. The Endocrine Society has stated there is little or no scientific evidence supporting claims that compounded "bioidentical" hormone therapy is safer or more effective than FDA-approved hormone therapy. That is a direct statement from the professional body representing endocrinologists, and it is worth taking seriously.
What Compounded HRT Means
Compounded medications are custom-prepared by a compounding pharmacy rather than manufactured by a pharmaceutical company. Compounding can allow for specific doses, routes, or formulations that are not available as standard commercial products.
Compounded HRT is not FDA-approved as a finished product. That does not mean every compounded preparation is unsafe - but it does mean these products have not been through the same review process for potency consistency, purity, safety labeling, and manufacturing standards that FDA-approved products have undergone. Studies have documented variability in compounded hormone preparations in ways that matter clinically.
ACOG has stated that compounded bioidentical menopausal hormone therapy should not be prescribed routinely when FDA-approved formulations exist, and that clinicians should counsel patients that FDA-approved menopausal hormone therapies are recommended over compounded preparations. This is not a fringe position. It reflects the consensus of the major professional bodies in women's health.
What FDA-Approved HRT Means
FDA-approved means a product has been reviewed for manufacturing quality, dose consistency, efficacy evidence, and safety labeling. It means the dose in the product is what the label says it is. It means the manufacturing process has been evaluated. It means the known risks and side effects have been documented and communicated.
FDA-approved does not mean a hormone is synthetic. Estradiol patches, estradiol gels, and oral micronized progesterone are all FDA-approved and all bioidentical in structure. The assumption that FDA-approved automatically means "conventional" or "synthetic" is part of the marketing confusion, not the clinical reality.
When Compounding May Be Clinically Appropriate
There are legitimate clinical situations where a compounded preparation is not just acceptable but may be the better fit - and this is the part of the conversation that gets flattened when the debate becomes all-or-nothing.
Compounding may be appropriate when a woman has a documented allergy or sensitivity to an inactive ingredient in an available FDA-approved formulation. Peanut oil is a real excipient in some commercial progesterone capsules. For a woman with a nut allergy, that is not a preference issue. It is a safety issue, and compounding solves it.
Compounding may also be appropriate when a specific dose is not commercially available and the clinical picture calls for it, when a route or delivery method does not exist as an FDA-approved product, or when a woman has not tolerated available commercial options and a compounded alternative is being considered under careful clinical supervision.
What matters in any of these situations is the clinical reasoning behind the choice, the quality of the compounding pharmacy, and the monitoring plan that follows. Compounding is a legitimate clinical tool. It is not a marketing category.
What Not to Assume
Do not assume compounded means better, more natural, or safer. The evidence does not support that assumption, and the major professional bodies are consistent on this point.
Do not assume FDA-approved means synthetic, inferior, or more risky than the alternative. Several of the most commonly used HRT formulations - estradiol and micronized progesterone - are both bioidentical and FDA-approved.
Do not assume bioidentical means risk-free. Hormones that are bioidentical in structure still require the same individualized risk assessment, monitoring, and clinical follow-up as any other HRT formulation.
Do not assume that a saliva test or urine test used by some compounding pharmacies to guide dosing reflects current clinical evidence. ACOG and The Menopause Society do not endorse these tests for guiding HRT dosing. Blood levels and symptom response, reviewed in clinical context, remain the standard approach.
Questions to Ask Before Starting Any HRT Formulation
What hormone is this and what is the dose? Is this FDA-approved? If it is compounded, what specific clinical reason makes it the right choice over an available FDA-approved option? What are the inactive ingredients and does anything in the formulation require attention given my history or sensitivities? How will this be monitored after I start? What symptoms or changes should prompt me to contact my clinician?
If you are being offered a compounded preparation as the first option without a clear explanation of why an FDA-approved formulation was not appropriate, that explanation is worth asking for.
When to Escalate Clinically
If you're currently using a compounded HRT preparation and it was not accompanied by a clear clinical rationale, a review of available FDA-approved options, or a monitoring plan - that conversation is worth having with your clinician.
If you're physically located in California, D.C., Georgia, Kentucky, Maryland, Ohio, Texas or Virginia at the time of your visit, the Reset Foundations Consult is where we review your symptoms, history, baseline labs, HRT questions, medication concerns, allergy or formulation issues and your next clinical step.
Take the Next Step
Book the Reset Foundations Consult
Frequently Asked Questions
What is the difference between bioidentical and compounded HRT? Bioidentical describes hormone structure - whether the hormone is chemically identical to what the body produces. Compounded describes how a medication is made - custom-prepared by a compounding pharmacy. These are different concepts. Some FDA-approved HRT products are bioidentical. Some compounded preparations are also bioidentical. The terms do not mean the same thing.
Is bioidentical HRT safer than conventional HRT? The Endocrine Society has stated there is little or no scientific evidence supporting claims that compounded bioidentical hormone therapy is safer or more effective than FDA-approved hormone therapy. Bioidentical in structure does not automatically mean safer in clinical practice. The same individualized risk assessment, monitoring, and follow-up applies regardless of the source.
Is compounded HRT regulated? Compounded medications are not FDA-approved as finished products and have not gone through the same review for potency consistency, purity, and manufacturing standards as FDA-approved products. Compounding pharmacies are subject to state pharmacy board oversight and, in some cases, FDA oversight, but the regulatory framework differs from that of commercially manufactured pharmaceuticals.
Are FDA-approved HRT options bioidentical? Some are. Estradiol - available as patches, gels, sprays, and some oral and vaginal formulations - is bioidentical. Oral micronized progesterone is bioidentical. These are FDA-approved products with a bioidentical hormone structure. The assumption that FDA-approved means synthetic is not accurate.
When might compounded HRT be appropriate? Compounding may be worth discussing when a woman has a documented allergy or sensitivity to an inactive ingredient in available FDA-approved formulations, when a specific dose or route is not commercially available and there is a clear clinical need, or when an FDA-approved option has not been tolerated and a compounded alternative is being considered under clinical supervision. It should not be the default choice when FDA-approved options exist.
What About Hormone Testing Beyond a Standard Blood Draw?
This is an area where you will hear different things from different clinicians, and the honest answer is that the conversation is more nuanced than a simple yes or no.
ACOG and The Menopause Society have stated they do not endorse saliva testing alone as the basis for guiding HRT dosing decisions, and that position reflects real concerns about the variability and standardization of saliva testing in isolation.
What a complete clinical picture often includes, however, is more than a single blood draw. Hormones fluctuate throughout the day, across the cycle, and in response to stress, sleep, and other variables. A clinician building a full picture of your hormonal status may use blood, urine, or saliva testing in combination - not because any single method tells the whole story, but because together they can reveal patterns that a snapshot blood level on a random Tuesday does not capture.
If you have questions about what testing was ordered and why, that is worth a direct conversation with your clinician. The right question is not which testing method is legitimate. The right question is whether the evaluation is comprehensive enough to guide the clinical decisions being made.
Should I ask for compounded HRT instead of what my doctor prescribed? That depends on why you are asking.
If you are asking because someone told you compounded HRT is more natural, safer, or more effective than FDA-approved options as a category - that claim is not supported by the evidence, and it is worth having an honest conversation with your clinician about what the research actually shows.
If you are asking because you have a specific clinical reason - a known allergy to an ingredient in a commercial formulation, a tolerability problem with available options, a dose or delivery method that does not exist as an FDA-approved product, or a preference your clinician has evaluated and discussed with you - that is a different conversation entirely and a legitimate one.
The goal is a protocol that fits your body, your history, your sensitivities, and your life. For some women that is an FDA-approved formulation. For others a compounded preparation is the right clinical choice. What matters is that the decision is made with a clinician who knows your full picture, not based on marketing language from either direction.
Sources
ACOG Clinical Consensus No. 8: Compounded Bioidentical Menopausal Hormone Therapy. Obstetrics and Gynecology. 2023. acog.org/clinical/clinical-guidance/clinical-consensus/articles/2023/11/compounded-bioidentical-menopausal-hormone-therapy
Endocrine Society. Position Statement: Compounded Bioidentical Hormone Therapy. endocrine.org/advocacy/position-statements/compounded-bioidentical-hormone-therapy
The Menopause Society (formerly NAMS). The 2022 Hormone Therapy Position Statement. Menopause. 2022. DOI: 10.1097/GME.0000000000002028
ACOG. Hormone Therapy for Menopause FAQ. acog.org/womens-health/faqs/hormone-therapy-for-menopause
This article is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. The information provided is intended to support informed conversations with your healthcare provider, not to replace clinical evaluation. Individual health decisions should be made in consultation with a licensed clinician who has reviewed your personal history, symptoms, labs, and medications.
Dr. Stacey Denise provides clinical care to patients physically located in California, D.C., Georgia, Kentucky, Maryland, Ohio, Texas or Virginia at the time of the visit.
